Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase ...

Summary by Enid News & Eagle
Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems,…

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase ...

Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems,…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news on Monday, June 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

FDA icon

FDA

Vancouver, British Columbia icon

Vancouver, British Columbia

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal